These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10804804)

  • 1. [Quality control on antimicrobial susceptibility testings].
    Aihara M
    Rinsho Byori; 2000 Jan; Suppl 111():142-9. PubMed ID: 10804804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quality control for antimicrobial susceptibility test using correlation between MIC results].
    Ueno T; Hiramatsu K; Nakano T; Koga S; Magari Y; Saikawa T; Nasu M
    Rinsho Byori; 2002 Jul; 50(7):706-11. PubMed ID: 12187710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).
    Cuenca-Estrella M; Arendrup MC; Chryssanthou E; Dannaoui E; Lass-Florl C; Sandven P; Velegraki A; Rodriguez-Tudela JL;
    Clin Microbiol Infect; 2007 Oct; 13(10):1018-22. PubMed ID: 17697001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility testing trends and accuracy in the United States. A review of the College of American Pathologists Microbiology Surveys, 1972-1989. Microbiology Resource Committee of the College of American Pathologists.
    Jones RN; Edson DC
    Arch Pathol Lab Med; 1991 May; 115(5):429-36. PubMed ID: 2021310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Improvement of routine works and quality control in mycobacterial laboratory].
    Suzuki K; Higuchi T
    Kekkaku; 2007 Mar; 82(3):217-27. PubMed ID: 17444126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility testing of Mycobacterium tuberculosis (EUCAST document E.DEF 8.1)--report of the Subcommittee on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis of the European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).
    Drobniewski F; Rüsch-Gerdes S; Hoffner S;
    Clin Microbiol Infect; 2007 Dec; 13(12):1144-56. PubMed ID: 17727670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The external quality assessment for Mycobacterium tuberculosis drug susceptibility testing by proficiency testing panel to the commercial laboratories].
    Mitarai S;
    Kekkaku; 2005 Apr; 80(4):349-58. PubMed ID: 15991600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study on resistance of Mycobacterium tuberculosis to four first-line anti-tuberculosis drugs in Japan: comparison of results in the local facilities and in the reference laboratory, in 1997].
    Hirano K; Wada M; Abe C; Aoyagi T
    Kekkaku; 2001 Jun; 76(6):461-71. PubMed ID: 11494526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [External quality assessment of drug susceptibility testing for Mycobacterium tuberculosis].
    Mitarai S; ;
    Kekkaku; 2006 Aug; 81(8):501-9. PubMed ID: 16972653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mycobacterial tests].
    Takashima T; Higuchi T
    Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical methods for establishing quality control ranges for antibacterial agents in Clinical and Laboratory Standards Institute susceptibility testing.
    Turnidge J; Bordash G
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2483-8. PubMed ID: 17438045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility testing practices for Streptococcus pneumoniae: results of a proficiency testing survey of clinical laboratories.
    Edson DC; Glick T; Massey LD
    Diagn Microbiol Infect Dis; 2006 Jul; 55(3):225-30. PubMed ID: 16545934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systems approach to improving antimicrobial susceptibility testing in clinical laboratories in the United States.
    Counts JM; Astles JR; Tenover FC; Hindler J
    J Clin Microbiol; 2007 Jul; 45(7):2230-4. PubMed ID: 17522281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data?
    Ernst EJ; Diekema DJ; BootsMiller BJ; Vaughn T; Yankey JW; Flach SD; Ward MM; Franciscus CL; Acosta E; Pfaller MA; Doebbeling BN
    Diagn Microbiol Infect Dis; 2004 Jun; 49(2):141-5. PubMed ID: 15183864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selection of appropriate antimicrobial agents to test and report by clinical microbiology laboratories].
    Koibuchi H; Shibuya Y; Kubo N; Kawano M; Itoh K
    Rinsho Byori; 2002 Oct; 50(10):992-9. PubMed ID: 12451681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardization of antimicrobial susceptibility testing.
    Barry AL
    Clin Lab Med; 1989 Jun; 9(2):203-19. PubMed ID: 2659241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Consensus on antimicrobial sensitivity tests in gram-positive cocci. Subcommittee on Antimicrobials, SADEBAC (Argentinian Society of Clinical Bacteriology), Argentinian Association of Microbiology].
    Famiglietti A; Quinteros M; Predari SC; Corso A; Lopardo H; Casellas JM; Bantar C; Couto E; Galas M; Goldberg M; Gutkind G; Kovensky Pupko J; Marín M; Nicola F; Pasterán F; Radice M; Soloaga R
    Rev Argent Microbiol; 2003; 35(1):29-40. PubMed ID: 12833678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility patterns of Staphylococcus aureus in Poland obtained by the National Quality Assurance Programme.
    Matynia B; Młodzinska E; Hryniewicz W
    Clin Microbiol Infect; 2005 May; 11(5):379-85. PubMed ID: 15819864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparisons of the in vitro susceptibility testing results for garenoxacin using six different national methods: report from the garenoxacin international bridging study.
    Jones RN; Gordon KA; Biedenbach DJ
    J Antimicrob Chemother; 2004 Feb; 53(2):258-65. PubMed ID: 14729758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-tuberculosis drug resistance survey in Japan, 2002: external quality assessment of results].
    Tuberculosis Research Committee
    Kekkaku; 2007 Mar; 82(3):155-64. PubMed ID: 17444118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.